Andreas Kluge, Chief Medical Officer at Telix Pharmaceuticals Ltd., holds 22.68M shares in Telix Pharmaceuticals Ltd. (Ticker: TLPPF). Most recently, Andreas Kluge Sold $2,000,000 shares of Telix Pharmaceuticals Ltd. on Jan 31, 2022 for an estimated value of 15.40M.